dc.relation.reference | Adachi T, M. S., Hirata A, Fukuda T, Kihara N, Makino S (1996). Detection of transforming growth factor-beta in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay. Clin Exp Allergy 26, 557-562.
Akbari, O., DeKruyff, R. H., and Umetsu, D. T. (2001). Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2, 725-731.
Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G., DeKruyff, R. H., and Umetsu, D. T. (2002). Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 8, 1024-1032.
Akdis, C. A., Akdis, M., Blesken, T., Wymann, D., Alkan, S. S., Muller, U., and Blaser, K. (1996). Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 98, 1676-1683.
Akdis, C. A., and Blaser, K. (1999). IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. Faseb J 13, 603-609.
Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B., and Blaser, K. (1998). Role of interleukin 10 in specific immunotherapy. J Clin Invest 102, 98-106.
Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 199, 1567-1575.
Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., and Romagnani, S. (2002). Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med 196, 379-387.
Asadullah, K., Sterry, W., and Volk, H. D. (2003). Interleukin-10 therapy--review of a new approach. Pharmacol Rev 55, 241-269.
Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811.
Barnes, P. J., and Lim, S. (1998). Inhibitory cytokines in asthma. Mol Med Today 4, 452-458.
Barnes, P. J. (2000). Endogenous inhibitory mechanisms in asthma. Am J Respir Crit Care Med 161, S176-181.
Barnes, P. J. (2002). Cytokine modulators as novel therapies for asthma. Annu Rev Pharmacol Toxicol 42, 81-98.
Barnes, P. J. (2001). Cytokine-directed therapies for asthma. J Allergy Clin Immunol 108, S72-76.
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., and O'Garra, A. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195, 603-616.
Behera, A. K., Kumar, M., Lockey, R. F., and Mohapatra, S. S. (2002). Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 13, 1697-1709.
Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., and Heath, W. R. (2002). The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196, 1099-1104.
Bentley, A. M., Meng, Q., Robinson, D. S., Hamid, Q., Kay, A. B., and Durham, S. R. (1993). Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 8, 35-42.
Borish, L., Aarons, A., Rumbyrt, J., Cvietusa, P., Negri, J., and Wenzel, S. (1996). Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 97, 1288-1296.
Borish, L. (1998). IL-10: evolving concepts. J Allergy Clin Immunol 101, 293-297.
Brandes, M. E., Allen, J. B., Ogawa, Y., and Wahl, S. M. (1991). Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 87, 1108-1113.
Bromberg, J. S., Boros, P., Ding, Y., Fu, S., Ku, T., Qin, L., and Sung, R. (2002). Gene transfer methods for transplantation. Methods Enzymol 346, 199-224.
Bruder, D., Probst-Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., and Hansen, W. (2004). Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34, 623-630.
Bruselle, G. G., Kips, J. C., Peleman, R. A., Joos, G. F., Devos, R. R., Tavernier, J. H., and Pauwels, R. A. (1997). Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am J Respir Cell Mol Biol 17, 767-771.
Burgess, J. K., Carlin, S., Pack, R. A., Arndt, G. M., Au, W. W., Johnson, P. R., Black, J. L., and Hunt, N. H. (2004). Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol 113, 683-689.
Busse, W. W. (1998). Leukotrienes and inflammation. Am J Respir Crit Care Med 157, S210-213.
Carter, L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., and Carreno, B. M. (2002). PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32, 634-643.
Cavani, A., Nasorri, F., Prezzi, C., Sebastiani, S., Albanesi, C., and Girolomoni, G. (2000). Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 114, 295-302.
Chand, N., Harrison, J. E., Rooney, S., Pillar, J., Jakubicki, R., Nolan, K., Diamantis, W., and Sofia, R. D. (1992). Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol 211, 121-123.
Chang, T. C., Kou, S. H., Chen, F. W., Chang, C. C., Liaw, K. Y., Chang-Chien, Y., Huang, T. S., Lin, C. C., and How, S. W. (1982). Cytopathology of thyroid cancer by fine needle aspiration with Liu's stain. Taiwan Yi Xue Hui Za Zhi 81, 1404-1412.
Chatenoud, L., Salomon, B., and Bluestone, J. A. (2001). Suppressor T cells--they're back and critical for regulation of autoimmunity! Immunol Rev 182, 149-163.
Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., and Bowcock, A. M. (2000). JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106, R75-81.
Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., and Weiner, H. L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
Chiang, D. J., Ye, Y. L., Chen, W. L., Lee, Y. L., Hsu, N. Y., and Chiang, B. L. (2003). Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation. Am J Respir Crit Care Med 168, 575-580.
Chu, H. W., Trudeau, J. B., Balzar, S., and Wenzel, S. E. (2000). Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 106, 1115-1123.
Chuang, Y. H., Fu, C. L., Lo, Y. C., and Chiang, B. L. (2004). Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther 11, 1497-1505.
Chuang, Y. H., Suen, J. L., and Chiang, B. L. (2006). Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma. J Mol Med.
Chung, K. F., and Barnes, P. J. (1999). Cytokines in asthma. Thorax 54, 825-857.
Constant, S. L., Brogdon, J. L., Piggott, D. A., Herrick, C. A., Visintin, I., Ruddle, N. H., and Bottomly, K. (2002). Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 110, 1441-1448.
Constant, S. L., Lee, K. S., and Bottomly, K. (2000). Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 30, 840-847.
Cookson, W. (1999). The alliance of genes and environment in asthma and allergy. Nature 402, B5-11.
Corry, D. B., Folkesson, H. G., Warnock, M. L., Erle, D. J., Matthay, M. A., Wiener-Kronish, J. P., and Locksley, R. M. (1996). Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183, 109-117.
Cottrez, F., Hurst, S. D., Coffman, R. L., and Groux, H. (2000). T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165, 4848-4853.
Coyle, A. J., Le Gros, G., Bertrand, C., Tsuyuki, S., Heusser, C. H., Kopf, M., and Anderson, G. P. (1995). Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 13, 54-59.
Creticos, P. S., Adkinson, N. F., Jr., Kagey-Sobotka, A., Proud, D., Meier, H. L., Naclerio, R. M., Lichtenstein, L. M., and Norman, P. S. (1985). Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest 76, 2247-2253.
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178, 1041-1048.
de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C., and Lambrecht, B. N. (2004). Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200, 89-98.
de Vries, J. E. (1998). The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102, 165-169.
Deguchi, Y. (1992). Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung. Ann Rheum Dis 51, 362-365.
Deguchi, Y., and Kishimoto, S. (1991). Spontaneous activation of transforming growth factor-beta gene transcription in broncho-alveolar mononuclear cells of individuals with systemic autoimmune diseases with lung involvement. Lupus 1, 27-30.
Demeure, C. E., Yang, L. P., Desjardins, C., Raynauld, P., and Delespesse, G. (1997). Prostaglandin E2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 27, 3526-3531.
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., and Bhardwaj, N. (2001). Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193, 233-238.
Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E., and Doetschman, T. (1995). Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A 92, 12215-12219.
Dow, S. W., Schwarze, J., Heath, T. D., Potter, T. A., and Gelfand, E. W. (1999). Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice. Hum Gene Ther 10, 1905-1914.
Egan, R. W., Umland, S. P., Cuss, F. M., and Chapman, R. W. (1996). Biology of interleukin-5 and its relevance to allergic disease. Allergy 51, 71-81.
Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A., and Bottomly, K. (2002). Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196, 1645-1651.
Enk, A. H., Saloga, J., Becker, D., M, B. P. m., and Knop, J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 179, 1397-1402.
Espevik, T., Figari, I. S., Shalaby, M. R., Lackides, G. A., Lewis, G. D., Shepard, H. M., and Palladino, M. A., Jr. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 166, 571-576.
Fahy, J. V., Corry, D. B., and Boushey, H. A. (2000). Airway inflammation and remodeling in asthma. Curr Opin Pulm Med 6, 15-20.
Faith, A., Akdis, C. A., Akdis, M., Simon, H. U., and Blaser, K. (1997). Defective TCR stimulation in anergized type 2 T helper cells correlates with abrogated p56(lck) and ZAP-70 tyrosine kinase activities. J Immunol 159, 53-60.
Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081-2095.
Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336.
Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L., and Hafler, D. A. (1996). Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98, 70-77.
Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875.
Gavett, S. H., O'Hearn, D. J., Li, X., Huang, S. K., Finkelman, F. D., and Wills-Karp, M. (1995). Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182, 1527-1536.
Gershon, R. K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737.
Gilliet, M., and Liu, Y. J. (2002). Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195, 695-704.
Gordon, J. R., Li, F., Nayyar, A., Xiang, J., and Zhang, X. (2005). CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. J Immunol 175, 1516-1522.
Graffi, S. J., Dekan, G., Stingl, G., and Epstein, M. M. (2002). Systemic administration of antigen-pulsed dendritic cells induces experimental allergic asthma in mice upon aerosol antigen rechallenge. Clin Immunol 103, 176-184.
Griffiths-Johnson, D. A., Collins, P. D., Rossi, A. G., Jose, P. J., and Williams, T. J. (1993). The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 197, 1167-1172.
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., and Roncarolo, M. G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
Grunig, G., Corry, D. B., Leach, M. W., Seymour, B. W., Kurup, V. P., and Rennick, D. M. (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185, 1089-1099.
Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G. L., Irvin, C. G., and Gelfand, E. W. (1997). Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156, 766-775.
Hamid, Q. A., and Minshall, E. M. (2000). Molecular pathology of allergic disease: I: lower airway disease. J Allergy Clin Immunol 105, 20-36.
Haneda, K., Sano, K., Tamura, G., Sato, T., Habu, S., and Shirato, K. (1997). TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 159, 4484-4490.
Haneda, K., Sano, K., Tamura, G., Shirota, H., Ohkawara, Y., Sato, T., Habu, S., and Shirato, K. (1999). Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Am J Respir Cell Mol Biol 21, 268-274.
Hansen, G., Berry, G., DeKruyff, R. H., and Umetsu, D. T. (1999). Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103, 175-183.
Hansen, G., McIntire, J. J., Yeung, V. P., Berry, G., Thorbecke, G. J., Chen, L., DeKruyff, R. H., and Umetsu, D. T. (2000). CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 105, 61-70.
Harizi, H., Juzan, M., Moreau, J. F., and Gualde, N. (2003). Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism. J Immunol 170, 139-146.
Havenith, C. E., Breedijk, A. J., Betjes, M. G., Calame, W., Beelen, R. H., and Hoefsmit, E. C. (1993). T cell priming in situ by intratracheally instilled antigen-pulsed dendritic cells. Am J Respir Cell Mol Biol 8, 319-324.
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., and Nussenzweig, M. C. (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194, 769-779.
Herrick, C. A., MacLeod, H., Glusac, E., Tigelaar, R. E., and Bottomly, K. (2000). Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 105, 765-775.
Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L. J., and Borish, L. (1998). Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 158, 1958-1962.
Hofstra, C. L., Van Ark, I., Hofman, G., Kool, M., Nijkamp, F. P., and Van Oosterhout, A. J. (1998). Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 161, 5054-5060.
Hogan, S. P., Foster, P. S., Tan, X., and Ramsay, A. J. (1998). Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur J Immunol 28, 413-423.
Hori, S., and Sakaguchi, S. (2004). Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6, 745-751.
Horwitz, D. A., Zheng, S. G., and Gray, J. D. (2003). The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leukoc Biol 74, 471-478.
Hsu, C. H., Chua, K. Y., Tao, M. H., Lai, Y. L., Wu, H. D., Huang, S. K., and Hsieh, K. H. (1996). Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 2, 540-544.
Hu, D., Ikizawa, K., Lu, L., Sanchirico, M. E., Shinohara, M. L., and Cantor, H. (2004). Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5, 516-523.
Huang, Q., Liu, D., Majewski, P., Schulte, L. C., Korn, J. M., Young, R. A., Lander, E. S., and Hacohen, N. (2001). The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870-875.
Huang, S. K., Xiao, H. Q., Kleine-Tebbe, J., Paciotti, G., Marsh, D. G., Lichtenstein, L. M., and Liu, M. C. (1995). IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155, 2688-2694.
Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., and Blessing, M. (2004). Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells. J Immunol 173, 6526-6531.
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176, 1693-1702.
Jahnsen, F. L., Moloney, E. D., Hogan, T., Upham, J. W., Burke, C. M., and Holt, P. G. (2001). Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 56, 823-826.
Jirapongsananuruk, O., and Leung, D. Y. (1997). Clinical applications of cytokines: new directions in the therapy of atopic diseases. Ann Allergy Asthma Immunol 79, 5-16; quiz 19-20.
John, M., Lim, S., Seybold, J., Jose, P., Robichaud, A., O'Connor, B., Barnes, P. J., and Chung, K. F. (1998). Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 157, 256-262.
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A. H. (2000). Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192, 1213-1222.
Jonuleit, H., Schmitt, E., Steinbrink, K., and Enk, A. H. (2001). Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 22, 394-400.
Juan, S. H., Lee, T. S., Tseng, K. W., Liou, J. Y., Shyue, S. K., Wu, K. K., and Chau, L. Y. (2001). Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104, 1519-1525.
Julia, V., Hessel, E. M., Malherbe, L., Glaichenhaus, N., O'Garra, A., and Coffman, R. L. (2002). A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16, 271-283.
Justice, J. P., Crosby, J., Borchers, M. T., Tomkinson, A., Lee, J. J., and Lee, N. A. (2002). CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. Am J Physiol Lung Cell Mol Physiol 282, L1066-1074.
Justice, J. P., Shibata, Y., Sur, S., Mustafa, J., Fan, M., and Van Scott, M. R. (2001). IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280, L363-368.
Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K., and Akdis, C. A. (2003). IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33, 1205-1214.
Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K., and Akdis, C. A. (2001). Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425.
Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., and Kapsenberg, M. L. (1997). IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159, 28-35.
Kamochi, M., Kamochi, F., Kim, Y. B., Sawh, S., Sanders, J. M., Sarembock, I., Green, S., Young, J. S., Ley, K., Fu, S. M., and Rose, C. E., Jr. (1999). P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver. Am J Physiol 277, L310-319.
Kanegae, Y., Makimura, M., and Saito, I. (1994). A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47, 157-166.
Kay, A. B. (2001). Allergy and allergic diseases. First of two parts. N Engl J Med 344, 30-37.
Kim, T. S., DeKruyff, R. H., Rupper, R., Maecker, H. T., Levy, S., and Umetsu, D. T. (1997). An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J Immunol 158, 4137-4144.
Knight, S. C., Mertin, J., Stackpoole, A., and Clark, J. (1983). Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci U S A 80, 6032-6035.
Kobayashi, T., Iijima, K., and Kita, H. (2003). Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 170, 5756-5763.
Koning, H., Neijens, H. J., Baert, M. R., Oranje, A. P., and Savelkoul, H. F. (1997). T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine 9, 427-436.
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
Kuipers, H., Hijdra, D., De Vries, V. C., Hammad, H., Prins, J. B., Coyle, A. J., Hoogsteden, H. C., and Lambrecht, B. N. (2003). Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J Immunol 171, 3645-3654.
Kuruvilla, A. P., Shah, R., Hochwald, G. M., Liggitt, H. D., Palladino, M. A., and Thorbecke, G. J. (1991). Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 88, 2918-2921.
Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M., and Feldmann, M. (1983). Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157, 1434-1447.
Lambrecht, B. N., De Veerman, M., Coyle, A. J., Gutierrez-Ramos, J. C., Thielemans, K., and Pauwels, R. A. (2000). Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106, 551-559.
Lambrecht, B. N., and Hammad, H. (2003). Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 3, 994-1003.
Lambrecht, B. N., Salomon, B., Klatzmann, D., and Pauwels, R. A. (1998). Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160, 4090-4097.
Larche, M., Robinson, D. S., and Kay, A. B. (2003). The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111, 450-463; quiz 464.
Lee, Y. L., Fu, C. L., Ye, Y. L., and Chiang, B. L. (1999). Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation. Scand J Immunol 49, 229-236.
Lee, Y. L., Tao, M. H., Chow, Y. H., and Chiang, B. L. (1998). Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy. Hum Gene Ther 9, 457-465.
Lee, Y. L., Ye, Y. L., Yu, C. I., Wu, Y. L., Lai, Y. L., Ku, P. H., Hong, R. L., and Chiang, B. L. (2001). Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 12, 2065-2079.
Letterio, J. J., and Roberts, A. B. (1998). Regulation of immune responses by TGF-beta. Annu Rev Immunol 16, 137-161.
Levings, M. K., and Roncarolo, M. G. (2000). T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J Allergy Clin Immunol 106, S109-112.
Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., and Roncarolo, M. G. (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166, 5530-5539.
Lewis, R. A., Austen, K. F., and Soberman, R. J. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323, 645-655.
Li, L., Xia, Y., Nguyen, A., Lai, Y. H., Feng, L., Mosmann, T. R., and Lo, D. (1999). Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162, 2477-2487.
Li, X. M., Chopra, R. K., Chou, T. Y., Schofield, B. H., Wills-Karp, M., and Huang, S. K. (1996). Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 157, 3216-3219.
Ling, E. M., Smith, T., Nguyen, X. D., Pridgeon, C., Dallman, M., Arbery, J., Carr, V. A., and Robinson, D. S. (2004). Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608-615.
Lloyd, C. M., Gonzalo, J. A., Coyle, A. J., and Gutierrez-Ramos, J. C. (2001). Mouse models of allergic airway disease. Adv Immunol 77, 263-295.
Lu, L., Lee, W. C., Takayama, T., Qian, S., Gambotto, A., Robbins, P. D., and Thomson, A. W. (1999). Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig). J Leukoc Biol 66, 293-296.
Lukacs, N. W. (2001). Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1, 108-116.
MacKenzie, J. R., Mattes, J., Dent, L. A., and Foster, P. S. (2001). Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 167, 3146-3155.
Maecker, H. T., Hansen, G., Walter, D. M., DeKruyff, R. H., Levy, S., and Umetsu, D. T. (2001). Vaccination with allergen-IL-18 fusion DNA protects against, and reverses established, airway hyperreactivity in a murine asthma model. J Immunol 166, 959-965.
Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., and Jonuleit, H. (2002). Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80, 477-483.
Makela, M. J., Kanehiro, A., Borish, L., Dakhama, A., Loader, J., Joetham, A., Xing, Z., Jordana, M., Larsen, G. L., and Gelfand, E. W. (2000). IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A 97, 6007-6012.
Maloy, K. J., and Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat Immunol 2, 816-822.
Manavalan, J. S., Kim-Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C., Mancini, D., Cortesini, R., and Suciu-Foca, N. (2004). Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16, 1055-1068.
Mark, D. A., Donovan, C. E., De Sanctis, G. T., He, H. Z., Cernadas, M., Kobzik, L., Perkins, D. L., Sharpe, A., and Finn, P. W. (2000). B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am J Respir Cell Mol Biol 22, 265-271.
Mathur, M., Herrmann, K., Qin, Y., Gulmen, F., Li, X., Krimins, R., Weinstock, J., Elliott, D., Bluestone, J. A., and Padrid, P. (1999). CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am J Respir Cell Mol Biol 21, 498-509.
Mattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, L., Hogan, S. P., Koskinen, A., McKenzie, A. N., Dent, L. A., et al. (2002). Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 195, 1433-1444.
Mauser, P. J., Pitman, A. M., Fernandez, X., Foran, S. K., Adams, G. K., 3rd, Kreutner, W., Egan, R. W., and Chapman, R. W. (1995). Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152, 467-472.
McWilliam, A. S., Napoli, S., Marsh, A. M., Pemper, F. L., Nelson, D. J., Pimm, C. L., Stumbles, P. A., Wells, T. N., and Holt, P. G. (1996). Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 184, 2429-2432.
Melillo, E., Woolley, K. L., Manning, P. J., Watson, R. M., and O'Byrne, P. M. (1994). Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 149, 1138-1141.
Minter, R. M., Ferry, M. A., Murday, M. E., Tannahill, C. L., Bahjat, F. R., Oberholzer, C., Oberholzer, A., LaFace, D., Hutchins, B., Wen, S., et al. (2001). Adenoviral delivery of human and viral IL-10 in murine sepsis. J Immunol 167, 1053-1059.
Minter, R. M., Ferry, M. A., Rectenwald, J. E., Bahjat, F. R., Oberholzer, A., Oberholzer, C., La Face, D., Tsai, V., Ahmed, C. M., Hutchins, B., et al. (2001). Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy. Proc Natl Acad Sci U S A 98, 277-282.
Minter, R. M., Rectenwald, J. E., Fukuzuka, K., Tannahill, C. L., La Face, D., Tsai, V., Ahmed, I., Hutchins, E., Moyer, R., Copeland, E. M., 3rd, and Moldawer, L. L. (2000). TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung. J Immunol 164, 443-451.
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765.
Moser, M., and Murphy, K. M. (2000). Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1, 199-205.
Mosmann, T. R., and Coffman, R. L. (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-173.
Muller, G., Muller, A., Tuting, T., Steinbrink, K., Saloga, J., Szalma, C., Knop, J., and Enk, A. H. (2002). Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J Invest Dermatol 119, 836-841.
Muller, U., Akdis, C. A., Fricker, M., Akdis, M., Blesken, T., Bettens, F., and Blaser, K. (1998). Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101, 747-754.
Murphy, K. M., Heimberger, A. B., and Loh, D. Y. (1990). Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250, 1720-1723.
Nakagome, K., Dohi, M., Okunishi, K., Komagata, Y., Nagatani, K., Tanaka, R., Miyazaki, J., and Yamamoto, K. (2005). In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J Immunol 174, 6955-6966.
Nakao, A. (2001). Is TGF-beta1 the key to suppression of human asthma? Trends Immunol 22, 115-118.
Nasser, S. M., Ying, S., Meng, Q., Kay, A. B., and Ewan, P. W. (2001). Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur J Immunol 31, 3704-3713.
Neurath, M. F., Fuss, I., Kelsall, B. L., Presky, D. H., Waegell, W., and Strober, W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183, 2605-2616.
Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999). Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151.
Oh, J. W., Seroogy, C. M., Meyer, E. H., Akbari, O., Berry, G., Fathman, C. G., Dekruyff, R. H., and Umetsu, D. T. (2002). CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J Allergy Clin Immunol 110, 460-468.
Ohno, I., Nitta, Y., Yamauchi, K., Hoshi, H., Honma, M., Woolley, K., O'Byrne, P., Tamura, G., Jordana, M., and Shirato, K. (1996). Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 15, 404-409.
Oro, A. S., Guarino, T. J., Driver, R., Steinman, L., and Umetsu, D. T. (1996). Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 97, 1402-1408.
Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., Foster, P. S., and Rothenberg, M. E. (2001). IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol 108, 594-601.
Prieto, J., Lensmar, C., Roquet, A., van der Ploeg, I., Gigliotti, D., Eklund, A., and Grunewald, J. (2000). Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 94, 806-814.
Randolph, D. A., Carruthers, C. J., Szabo, S. J., Murphy, K. M., and Chaplin, D. D. (1999). Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 162, 2375-2383.
Raz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J. A., Roman, M., Swain, S. L., Spiegelberg, H. L., and Carson, D. A. (1996). Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 93, 5141-5145.
Read, S., Malmstrom, V., and Powrie, F. (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192, 295-302.
Redington, A. E., Madden, J., Frew, A. J., Djukanovic, R., Roche, W. R., Holgate, S. T., and Howarth, P. H. (1997). Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 156, 642-647.
Reis e Sousa, C. (2001). Dendritic cells as sensors of infection. Immunity 14, 495-498.
Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R., and Liu, Y. J. (1999). Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
Robinson, D. S. (2000). Th-2 cytokines in allergic disease. Br Med Bull 56, 956-968.
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., and Kay, A. B. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326, 298-304.
Robinson, D. S., Tsicopoulos, A., Meng, Q., Durham, S., Kay, A. B., and Hamid, Q. (1996). Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 14, 113-117.
Rocklin, R. E., Sheffer, A. L., Greineder, D. K., and Melmon, K. L. (1980). Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 302, 1213-1219.
Romagnani, S. (1994). Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 6, 838-846.
Roncarolo, M. G., and Levings, M. K. (2000). The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12, 676-683.
Rothenberg, M. E. (1999). Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 21, 291-295.
Rothenberg, M. E., Ownbey, R., Mehlhop, P. D., Loiselle, P. M., van de Rijn, M., Bonventre, J. V., Oettgen, H. C., Leder, P., and Luster, A. D. (1996). Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol Med 2, 334-348.
Saini, S. S., and MacGlashan, D. (2002). How IgE upregulates the allergic response. Curr Opin Immunol 14, 694-697.
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164.
Salek-Ardakani, S., Song, J., Halteman, B. S., Jember, A. G., Akiba, H., Yagita, H., and Croft, M. (2003). OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 198, 315-324.
Scheeren, R. A., Koopman, G., Van der Baan, S., Meijer, C. J., and Pals, S. T. (1991). Adhesion receptors involved in clustering of blood dendritic cells and T lymphocytes. Eur J Immunol 21, 1101-1105.
Schwartz, R. H. (2003). T cell anergy. Annu Rev Immunol 21, 305-334.
Scott, P., Natovitz, P., Coffman, R. L., Pearce, E., and Sher, A. (1988). Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 168, 1675-1684.
Shevach, E. M. (2001). Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193, F41-46.
Shevach, E. M. (2002). CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2, 389-400.
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., and et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
Singer, A. J., and Clark, R. A. (1999). Cutaneous wound healing. N Engl J Med 341, 738-746.
Spight, D., Zhao, B., Haas, M., Wert, S., Denenberg, A., and Shanley, T. P. (2005). Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am J Physiol Lung Cell Mol Physiol 288, L251-265.
Stampfli, M. R., Cwiartka, M., Gajewska, B. U., Alvarez, D., Ritz, S. A., Inman, M. D., Xing, Z., and Jordana, M. (1999). Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am J Respir Cell Mol Biol 21, 586-596.
Stampfli, M. R., Wiley, R. E., Neigh, G. S., Gajewska, B. U., Lei, X. F., Snider, D. P., Xing, Z., and Jordana, M. (1998). GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest 102, 1704-1714.
Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., and Enk, A. H. (1999). Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93, 1634-1642.
Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J., and Enk, A. H. (1997). Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159, 4772-4780.
Steinman, R. M., and Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137, 1142-1162.
Zuany-Amorim, C., Sawicka, E., Manlius, C., Le Moine, A., Brunet, L. R., Kemeny, D. M., Bowen, G., Rook, G., and Walker, C. (2002). Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8, 625-629.
Stumbles, P. A., Thomas, J. A., Pimm, C. L., Lee, P. T., Venaille, T. J., Proksch, S., and Holt, P. G. (1998). Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 188, 2019-2031.
Suen, J. L., Wu, C. H., Chen, Y. Y., Wu, W. M., and Chiang, B. L. (2001). Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB x NZW F1 mice. Immunology 103, 301-309.
Sung, S., Rose, C. E., and Fu, S. M. (2001). Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J Immunol 166, 1261-1271.
Suzuki, M., Suzuki, S., Yamamoto, N., Komatsu, S., Inoue, S., Hashiba, T., Nishikawa, M., and Ishigatsubo, Y. (2000). Immune responses against replication-deficient adenovirus inhibit ovalbumin-specific allergic reactions in mice. Hum Gene Ther 11, 827-838.
Swirski, F. K., Sajic, D., Robbins, C. S., Gajewska, B. U., Jordana, M., and Stampfli, M. R. (2002). Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor. J Immunol 169, 3499-3506.
Szczeklik, A., Mastalerz, L., Nizankowska, E., and Cmiel, A. (1996). Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 153, 567-571.
Tanaka, H., Masuda, T., Tokuoka, S., Komai, M., Nagao, K., Takahashi, Y., and Nagai, H. (2001). The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 50, 616-624.
Tang, M. L., Kemp, A. S., Thorburn, J., and Hill, D. J. (1994). Reduced interferon-gamma secretion in neonates and subsequent atopy. Lancet 344, 983-985.
Taube, C., Dakhama, A., and Gelfand, E. W. (2004). Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 135, 173-186.
Thomson, A. W. (2002). Designer dendritic cells for transplant tolerance. Transplant Proc 34, 2727-2728.
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., and Palladino, M. A. (1992). Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci U S A 89, 7375-7379.
Tournoy, K. G., Kips, J. C., and Pauwels, R. A. (2000). Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 30, 775-783.
Tsitoura, D. C., DeKruyff, R. H., Lamb, J. R., and Umetsu, D. T. (1999). Intranasal exposure to protein antigen induces immunological tolerance mediated by functionally disabled CD4+ T cells. J Immunol 163, 2592-2600.
Umetsu, D. T., and DeKruyff, R. H. (1997). TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 100, 1-6.
Valenta, R. (2002). The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2, 446-453.
Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K., et al. (2002). Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430.
van Neerven, R. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., and Ipsen, H. (1999). Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163, 2944-2952.
van Rijt, L. S., and Lambrecht, B. N. (2001). Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse. Microsc Res Tech 53, 256-272.
van Scott, M. R., Justice, J. P., Bradfield, J. F., Enright, E., Sigounas, A., and Sur, S. (2000). IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol 278, L667-674.
Vignola, A. M., Chanez, P., Chiappara, G., Merendino, A., Pace, E., Rizzo, A., la Rocca, A. M., Bellia, V., Bonsignore, G., and Bousquet, J. (1997). Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 156, 591-599.
Vignola, A. M., Chanez, P., Chiappara, G., Merendino, A., Zinnanti, E., Bousquet, J., Bellia, V., and Bonsignore, G. (1996). Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 106, 114-119.
Vu, Q., McCarthy, K. M., McCormack, J. M., and Schneeberger, E. E. (2002). Lung dendritic cells are primed by inhaled particulate antigens, and retain MHC class II/antigenic peptide complexes in hilar lymph nodes for a prolonged period of time. Immunology 105, 488-498.
Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis, N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B., and et al. (1988). Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol 140, 3026-3032.
Walter, D. M., Wong, C. P., DeKruyff, R. H., Berry, G. J., Levy, S., and Umetsu, D. T. (2001). Il-18 gene transfer by adenovirus prevents the development of and reverses established allergen-induced airway hyperreactivity. J Immunol 166, 6392-6398.
Wang, C. C., Fu, C. L., Yang, Y. H., Lo, Y. C., Wang, L. C., Chuang, Y. H., Chang, D. M., and Chiang, B. L. (2006). Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther.
Wang, D. Y., Chang, D. B., Kuo, S. H., Yang, S., Shiah, D. C., Chou, H. T., and Luh, K. T. (1995). Systemic lupus erythematosus presenting as pleural effusion: report of a case. J Formos Med Assoc 94, 746-749.
Weiner, H. L. (1997). Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48, 341-351.
Weiner, H. L. (2001). Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182, 207-214.
Wierenga, E. A., Snoek, M., Jansen, H. M., Bos, J. D., van Lier, R. A., and Kapsenberg, M. L. (1991). Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 147, 2942-2949.
Wiktor-Jedrzejczak, W. (1993). Eosinophil development. Immunol Today 14, 238.
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27, 18-20.
Wills-Karp, M. (1999). Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17, 255-281.
Wills-Karp, M., Santeliz, J., and Karp, C. L. (2001). The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1, 69-75.
Yang, X., Wang, S., Fan, Y., and Han, X. (2000). IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 30, 382-391.
Ye, Y. L., Huang, W. C., Lee, Y. L., and Chiang, B. L. (2002). Interleukin-12 inhibits eotaxin secretion of cultured primary lung cells and alleviates airway inflammation in vivo. Cytokine 19, 76-84.
Ye, Y. L., Lee, Y. L., Chuang, Z. J., Lai, H. J., Chen, C. C., Tao, M. H., and Chiang, B. L. (2004). Dendritic cells modulated by cytokine-expressing adenoviruses alleviate eosinophilia and airway hyperresponsiveness in an animal model of asthma. J Allergy Clin Immunol 114, 88-96.
Yeung, V. P., Gieni, R. S., Umetsu, D. T., and DeKruyff, R. H. (1998). Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J Immunol 161, 4146-4152.
Zhang, M., Wang, Q., Liu, Y., Sun, Y., Ding, G., Fu, Z., Min, Z., Zhu, Y., and Cao, X. (2004). Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival. J Mol Med 82, 240-249.
Zuany-Amorim, C., Haile, S., Leduc, D., Dumarey, C., Huerre, M., Vargaftig, B. B., and Pretolani, M. (1995). Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 95, 2644-2651.
Enk, A. H., and Katz, S. I. (1992). Identification and induction of keratinocyte-derived IL-10. J Immunol 149, 92-95.
Kang, K., Hammerberg, C., Meunier, L., and Cooper, K. D. (1994). CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 153, 5256-5264.
Ding, L., and Shevach, E. M. (1992). IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148, 3133-3139.
Enk, A. H., Angeloni, V. L., Udey, M. C., and Katz, S. I. (1993). Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol 151, 2390-2398.
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444-3451.
Macatonia, S. E., Doherty, T. M., Knight, S. C., and O'Garra, A. (1993). Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150, 3755-3765.
Peguet-Navarro, J., Moulon, C., Caux, C., Dalbiez-Gauthier, C., Banchereau, J., and Schmitt, D. (1994). Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 24, 884-891.
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., and Shevach, E. M. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151, 1224-1234.
Berg, D. J., Leach, M. W., Kuhn, R., Rajewsky, K., Muller, W., Davidson, N. J., and Rennick, D. (1995). Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182, 99-108.
Cai, G., Kastelein, R. A., and Hunter, C. A. (1999). IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol 29, 2658-2665.
Dokka, S., Shi, X., Leonard, S., Wang, L., Castranova, V., and Rojanasakul, Y. (2001). Interleukin-10-mediated inhibition of free radical generation in macrophages. Am J Physiol Lung Cell Mol Physiol 280, L1196-1202.
Gazzinelli, R. T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., Muller, W., Trinchieri, G., and Sher, A. (1996). In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157, 798-805.
Ishida, H., Hastings, R., Kearney, J., and Howard, M. (1992). Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175, 1213-1220.
Kasama, T., Strieter, R. M., Lukacs, N. W., Burdick, M. D., and Kunkel, S. L. (1994). Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 152, 3559-3569.
Murray, P. J., and Young, R. A. (1999). Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67, 3087-3095.
Sozzani, S., Ghezzi, S., Iannolo, G., Luini, W., Borsatti, A., Polentarutti, N., Sica, A., Locati, M., Mackay, C., Wells, T. N., et al. (1998). Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187, 439-444.
Usacheva, A., Kotenko, S., Witte, M. M., and Colamonici, O. R. (2002). Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. J Immunol 169, 1302-1308.
Usacheva, A., Sandoval, R., Domanski, P., Kotenko, S. V., Nelms, K., Goldsmith, M. A., and Colamonici, O. R. (2002). Contribution of the Box 1 and Box 2 motifs of cytokine receptors to Jak1 association and activation. J Biol Chem 277, 48220-48226.
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F., and Groux, H. (2003). Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605-617.
Willems, F., Marchant, A., Delville, J. P., Gerard, C., Delvaux, A., Velu, T., de Boer, M., and Goldman, M. (1994). Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24, 1007-1009.
Yang, X., Gartner, J., Zhu, L., Wang, S., and Brunham, R. C. (1999). IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol 162, 1010-1017.
Jinquan, T., Larsen, C. G., Gesser, B., Matsushima, K., and Thestrup-Pedersen, K. (1993). Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 151, 4545-4551.
Kotenko, S. V., Izotova, L. S., Pollack, B. P., Muthukumaran, G., Paukku, K., Silvennoinen, O., Ihle, J. N., and Pestka, S. (1996). Other kinases can substitute for Jak2 in signal transduction by interferon-gamma. J Biol Chem 271, 17174-17182.
Sewnath, M. E., Olszyna, D. P., Birjmohun, R., ten Kate, F. J., Gouma, D. J., and van Der Poll, T. (2001). IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166, 6323-6331.
Takayama, T., Morelli, A. E., Onai, N., Hirao, M., Matsushima, K., Tahara, H., and Thomson, A. W. (2001). Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol 166, 7136-7143.
Vazquez-Torres, A., Jones-Carson, J., Wagner, R. D., Warner, T., and Balish, E. (1999). Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun 67, 670-674.
Finbloom, D. S., and Winestock, K. D. (1995). IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 155, 1079-1090.
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999). SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597-608.
Ding, Y., Chen, D., Tarcsafalvi, A., Su, R., Qin, L., and Bromberg, J. S. (2003). Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J Immunol 170, 1383-1391.
Hanada, T., Yoshida, T., Kinjyo, I., Minoguchi, S., Yasukawa, H., Kato, S., Mimata, H., Nomura, Y., Seki, Y., Kubo, M., and Yoshimura, A. (2001). A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J Biol Chem 276, 40746-40754.
Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W. G., Jr., Conaway, R. C., and Conaway, J. W. (1998). The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12, 3872-3881.
Naka, T., Tsutsui, H., Fujimoto, M., Kawazoe, Y., Kohzaki, H., Morita, Y., Nakagawa, R., Narazaki, M., Adachi, K., Yoshimoto, T., et al. (2001). SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14, 535-545.
Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E., and Schreiber, R. D. (1996). Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem 271, 27954-27961.
Wehinger, J., Gouilleux, F., Groner, B., Finke, J., Mertelsmann, R., and Weber-Nordt, R. M. (1996). IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 394, 365-370.
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., and Yoshimura, A. (1999). The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. Embo J 18, 1309-1320.
Zhang, J. G., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R., Hausmann, G., et al. (1999). The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96, 2071-2076.
Riley, J. K., Takeda, K., Akira, S., and Schreiber, R. D. (1999). Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 274, 16513-16521.
Schottelius, A. J., Mayo, M. W., Sartor, R. B., and Baldwin, A. S., Jr. (1999). Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 274, 31868-31874.
Shames, B. D., Selzman, C. H., Meldrum, D. R., Pulido, E. J., Barton, H. A., Meng, X., Harken, A. H., and McIntyre, R. C., Jr. (1998). Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 10, 389-394.
Stearns, M. E., Hu, Y., and Wang, M. (2003). IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines. Oncogene 22, 3781-3791.
Wang, M., Hu, Y., and Stearns, M. E. (2003). A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells. Br J Cancer 88, 1605-1614.
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. (1995). Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270, 9558-9563 | en |